 |
For all your Quality Management and Continual Improvement Initiatives and Standards
|
| View previous topic :: View next topic |
| Author |
Message |
GaryW Site Admin

Joined: 14 Oct 2005 Posts: 106545 Location: Adelaide, Australia

|
Posted: Sat Mar 13, 2010 7:48 am Post subject: Access Pharmaceuticals Reports Significant Oral Bioavailability Of Cobalamin(TM) Oral Insulin In Additional Studies |
|
|
ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) announced that it has received reports of significant bioavailability of orally delivered insulin in two independently-conducted animal studies. The studies, which confirm earlier findings, were performed as part of on-going work with commercial collaborators that are evaluating Access' Cobalamin™ Oral Drug Delivery Technology...
Read more...
Source: Pharma Industry / Biotech Industry News From Medical News Today
Latest Health News and Medical News posted throughout the day, every day. _________________ Regards,
Gary Wilkinson
Founder & Principal Consultant
SQR Consulting |
|
| Back to top |
|
 |
|
|
You cannot post new topics in this forum You cannot reply to topics in this forum You cannot edit your posts in this forum You cannot delete your posts in this forum You cannot vote in polls in this forum You cannot attach files in this forum You cannot download files in this forum
|
|
|
© 2005 SQR Consulting - All rights reserved
ABN : 60512166070
Powered by phpBB © 2001, 2005 phpBB Group
|